CLPX mutations contribute to metabolic disorders in human patients and animal models (12, 13, 17, 33), and CLPX regulates heme synthesis in erythroid cells by control of mitochondrial heme synthesis and iron utilization. The gene discussed is CLPX; the disease is metabolic disease.